Literature DB >> 10646787

Fetal lung development: airway pressure enhances the expression of developmental genes.

R E Cilley1, S E Zgleszewski, M R Chinoy.   

Abstract

BACKGROUND/
PURPOSE: The mechanisms by which static airway pressures in the developing lung affect development are unknown. The in vitro murine fetal lung model with airway ligation reproduces the phenomenon of intraluminal airway pressure in developing lungs. We have applied the technique of differential display of mRNAs to fetal murine lungs that were maintained in organ culture with and without tracheal ligation. The goal of this investigation was to identify genes that are induced or enhanced by airway pressure during lung development.
METHODS: Fetuses were harvested from CD-1 mice on gestational day (Gd) 14. The lungs were removed and trachea either transected or ligated and organ cultured for 7 days. Total RNA was extracted from cultured unligated controls and ligated lungs. Reverse transcription (RT) of the purified total RNA from each pooled sample was performed with anchor primer H-T11G or C and one of 24 arbitrary primers followed by polymerase chain reaction (PCR) of the RT mixtures. PCR products were electrophoresed on a DNA sequencing gel. Differentially expressed cDNA bands of interest were cut from the dried gel. Each cDNA was then reamplified. Reamplified cDNAs were extracted, PCR amplified, cloned, and sequenced for homology to existing sequences in the GenBank database.
RESULTS: Sequencing identified 4 differentially expressed genes enhanced by tracheal ligation: hepatoma-derived growth factor (HDGF), ribosomal protein S24, stathmin, and parathyroid hormone (PTH).
CONCLUSIONS: Genes enhanced by airway pressure or tracheal ligation are mitogenic for fibroblasts, correlate with cell proliferation, regulate cell proliferation and differentiation, and may play a role in growth in distal lung and type II cell differentiation. Further work is necessary to identify the mechanisms by which these genes influence lung maturational processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646787     DOI: 10.1016/s0022-3468(00)80026-3

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  14 in total

1.  Abnormal control of lung branching in experimental esophageal atresia.

Authors:  Ana Catarina Fragoso; Rosa Aras-Lopez; Leopoldo Martinez; José Estevão-Costa; Juan A Tovar
Journal:  Pediatr Surg Int       Date:  2013-02       Impact factor: 1.827

2.  Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.

Authors:  Hirayuki Enomoto; Hideji Nakamura; Naoko Komatsu-Kanatani; Yu Liu; Kenya Yoshida; Yorihide Okuda; Teruhisa Yamamoto; Weidong Liu; Shuhei Nishiguchi
Journal:  World J Hepatol       Date:  2009-10-31

3.  Abnormal development of tracheal innervation in rats with experimental diaphragmatic hernia.

Authors:  Federica Pederiva; Rosa Aras Lopez; Leopoldo Martinez; Juan A Tovar
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

4.  Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor.

Authors:  Fei Liao; Weiguo Dong; Lifang Fan
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

5.  Expression patterns and different subcellular localization of the growth factors HDGF (hepatoma-derived growth factor) and HRP-3 (HDGF-related protein-3) suggest functions in addition to their mitogenic activity.

Authors:  Mekky M Abouzied; Stephan L Baader; Frank Dietz; Joachim Kappler; Volkmar Gieselmann; Sebastian Franken
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

6.  Tracheal occlusion increases the rate of epithelial branching of embryonic mouse lung via the FGF10-FGFR2b-Sprouty2 pathway.

Authors:  Mathieu Unbekandt; Pierre-Marie del Moral; Frederic G Sala; Saverio Bellusci; David Warburton; Vincent Fleury
Journal:  Mech Dev       Date:  2007-11-07       Impact factor: 1.882

7.  Expression of hepatoma-derived growth factor family members in the adult central nervous system.

Authors:  Heba M El-Tahir; Frank Dietz; Ralf Dringen; Kerstin Schwabe; Karen Strenge; Sørge Kelm; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Neurosci       Date:  2006-01-23       Impact factor: 3.288

8.  The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.

Authors:  Behrang Kazeminezhad; Behdad Baradaran; Mohammad Reza Hafezi Ahmadi
Journal:  J Family Med Prim Care       Date:  2017 Oct-Dec

9.  Hepatoma-derived growth factor and its role in keloid pathogenesis.

Authors:  B N S Ooi; A Mukhopadhyay; J Masilamani; D V Do; C P Lim; X M Cao; I J Lim; L Mao; H N Ren; H Nakamura; T T Phan
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

10.  Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.

Authors:  Yang Yang; Shengru Liang; Yuqian Li; Fei Gao; Longlong Zheng; Shilai Tian; Pu Yang; Lihong Li
Journal:  Oncol Lett       Date:  2017-10-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.